The global disposable syringes market was valued at USD 7.55 billion in 2020 and is expected to grow at a CAGR of 5.9% during the forecast period. Disposable syringes are disposables that are used by doctors only once to inject medicines for the treatment of diseases. These syringes are made of plastic material which is used in the field of medical and veterinary science.
These syringes are cost-effective and are ready to use in a sterilized condition that reduces the chances of contamination and spread of infection to the patient. These products are ready to use which has also helped in controlling the spread of AIDS in individuals.
Know more about this report: request for sample pages
The disposable syringes market is primarily driven by increasing demand for these products for giving medication through intravenous or intramuscular ways for treating the diseases. Additionally, the increase in the production of these syringes across the globe by the manufactures, and the need for controlling the cross-contamination and spread of infection also boost the industry growth during the forecast period.
The disposable syringes market is a wide industry with a huge potential owing to increasing R&D for developing new chemicals that are used in the manufacturing of these products, and continuous clinical trials to also promote the industry growth. However, increasing biologics demand would impede the industry growth during the forecast period.
Know more about this report: request for sample pages
By Type |
By Application |
By Region |
|
|
|
Know more about this report: request for sample pages
Based on the therapy type the industry is segmented as safety and conventional needles. The safety segment dominated the industry in 2020 owing to the cost-effectiveness of these types as compared to conventional syringes, and rising concern for reducing the infection to the patient which in return reduces the cost of treatment.
On the basis of application, the industry is segmented as immunization injections, and therapeutic injections. Therapeutic injections segment to dominate the industry over the forecast period. The growth of this segment is majorly driven by the increasing number of individuals suffering from diabetes, and other therapeutically treated diseases.
Geographically, the industry is segmented across North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is the dominating region for the disposable syringe industry followed by Europe. The major factors promoting the North American industry growth are the rising need for injectable drugs, and a large number of disposable syringes manufacturers in this region.
Similarly, the manufacturers in this region are continuously focusing on product development that has also driven the industry growth. The European disposable syringe industry is estimated to be the second most leading region. The European market hosts several headquarters of some of the key players such as Novo Nordisk, Covidien (Medtronic, Inc), B Braun, and Fresenius Kabi.
In addition, the European governments have authorized the usage of safety-engineered devices in healthcare services. Moreover, the European Pharmacopeia Convention and the U.S. Pharmacopeia Convention are two of the leading establishments that set high standards for the safety of healthcare workers, as well as patients. the European Disposable Syringe market, is estimated to generate lucrative growth opportunities during the forecast period.
The major players operating in the disposable syringe market include Fresenius Kabi AG, Becton, Dickinson, and Company, Baxter International, Inc., UltiMed, Inc. Flextronics International Vita Needle Company, Terumo Corporation, Novo Nordisk, Henke-Sass, Wolf, Covidien, Braun Medical, Inc., Retractable Technologies, Inc., among others.
These leading players in the disposable syringe market are introducing innovative products in the market to cater to consumers. The global players are entering new markets in developing regions to expand their customer base and strengthen their market presence.